Please provide your email address to receive an email when new articles are posted on . The mean successfully completed dose increased from 48 mg to 2,723 mg of peanut protein by 48 months. 70% ...

Children with peanut allergies treated with peanut oral immunotherapy for 3 years can tolerate increasingly higher exposures to peanuts. But avoidance of peanut-protein exposure for just a single ...

Please provide your email address to receive an email when new articles are posted on . When peanut introduction fails, peanut OIT for infants should be offered as soon as possible via shared decision ...

Oral immunotherapy (pOIT) significantly increases peanut challenge tolerance in children compared to avoidance, with 74% success in the pOIT group versus 11% in the avoidance group. The study ...

PRT120 is an investigational peanut oral immunotherapy designed to induce immune remission rather than temporary ...

Children with high-threshold peanut allergies may have a new path toward desensitization through a simple and inexpensive method. A recent study suggests that gradually increasing daily doses of store ...

Based on focus groups with children and young people with peanut allergy, experts have published guidance for clinicians working in the UK’s National Health Service (NHS) to help them safely and ...

The majority of young children treated with peanut immunotherapy achieved desensitization after two and a half years of treatment, and one in five remained in remission 26 weeks after treatment ended, ...